TP53 and neoplasm: Cells expressing a different p53 polymorphism (S47) show reduced ability to activate ferroptosis (Leu et al., 2019) and increased glycolysis (Barnoud et al., 2019b), correlating with reduced tumour suppressor activity of this variant (Jennis et al., 2016).